Cargando…
The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis()
INTRODUCTION: Mucopolysaccharidosis (MPS) is a lysosomal storage disease caused by deficiency of α-l-iduronidase. The otolaryngological findings include hearing loss, otorrhea, recurrent otitis, hypertrophy of tonsils and adenoid, recurrent rhinosinusitis, speech disorders, snoring, oral breathing a...
Autores principales: | Dualibi, Ana Paula Fiuza Funicello, Martins, Ana Maria, Moreira, Gustavo Antônio, de Azevedo, Marisa Frasson, Fujita, Reginaldo Raimundo, Pignatari, Shirley Shizue Nagata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444600/ https://www.ncbi.nlm.nih.gov/pubmed/26750310 http://dx.doi.org/10.1016/j.bjorl.2015.09.006 |
Ejemplares similares
-
Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I
por: Giugliani, Roberto, et al.
Publicado: (2017) -
A small contribution on the history of the official implementation of the pediatric otorhinolaryngology in Brazil
por: Chen, Vitor Guo, et al.
Publicado: (2023) -
Assessment of cognitive learning function in children with obstructive sleep breathing disorders
por: Uema, Sandra Fumi Hamasaki, et al.
Publicado: (2015) -
Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series
por: Horovitz, Dafne Dain Gandelman, et al.
Publicado: (2016) -
Behavioral evaluation in children with obstructive sleep disorders
por: Uema, Sandra Fumi Hamasaki, et al.
Publicado: (2015)